Ray et al. report on a bias for monomeric CXCL12 to initiate G protein-coupled signaling and for dimeric CXCL12 to rather promote recruitment of β-arrestin-2 to CXCR4, as shown in vitro in breast cancer cells (129). Here, CXCL12 is linked to breast carcinoma.